Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production.

about

Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine.

P2860

Q52714655-6BA0E62D-3DAF-4B7C-905A-49002E817AF0

P2860

Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production.

Item

http://www.wikidata.org/entity/Q50146298

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production.

@en

Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production.

@nl

type

Item

label

Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production.

@en

Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production.

@nl

prefLabel

Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production.

@en

Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production.

@nl

P1476

Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production.

@en

P2093

Carlo G Tocchetti

http://www.w3.org/2001/XMLSchema#string

Carlo Maurea

http://www.w3.org/2001/XMLSchema#string

Chiara D'Avino

http://www.w3.org/2001/XMLSchema#string

Claudio Arra

http://www.w3.org/2001/XMLSchema#string

Fabio Di Lisa

http://www.w3.org/2001/XMLSchema#string

Gerolama Condorelli

http://www.w3.org/2001/XMLSchema#string

Giovanna Piscopo

http://www.w3.org/2001/XMLSchema#string

Michele Russo

http://www.w3.org/2001/XMLSchema#string

Nicola Maurea

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiac toxicity of trastuzumab in elderly patients with breast cancer

Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions-A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of Cardiology

Cardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction

Pharmacology at work for cardio-oncology: ranolazine to treat early cardiotoxicity induced by antitumor drugs

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy

Dose translation from animal to human studies revisited

A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation

Oxygen, oxidative stress, hypoxia, and heart failure.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHYS.2018.00038

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29467663

http://www.w3.org/2001/XMLSchema#string

P932

5808165

http://www.w3.org/2001/XMLSchema#string

Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production.

about

P2860

P2860

Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932